Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Riken Vitamin Co's Operating Income for the
three
months ended in Mar. 2026 was 円1,184 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was 円6,901 Mil.
Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Riken Vitamin Co's annualizedROC % for the quarter that ended in Mar. 2026 was 3.28%.
Riken Vitamin Co's annualizedROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 12.54%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.
Be Aware
Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Riken Vitamin Co Operating Income Related Terms
Riken Vitamin Co Operating Income Historical Data
* Premium members only.
The historical data trend for Riken Vitamin Co's Operating Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.
Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円6,901 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Riken Vitamin Co (TSE:4526) has a Operating Income of 円6,901 Mil as of Mar. 2026. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Riken Vitamin Co and its competitors.
Is Riken Vitamin Co's Operating Income too high?
Riken Vitamin Co's current Operating Income is 円6,901 Mil. Overall, Riken Vitamin Co has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Riken Vitamin Co's Operating Income compare to KHC and GIS?
Riken Vitamin Co's Operating Income of 円6,901 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Consumer Packaged Goods company?
A good Operating Income depends on the Consumer Packaged Goods industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Riken Vitamin Co and its competitors. Riken Vitamin Co's current Operating Income is 円6,901 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Riken Vitamin Co stock overvalued right now?
Based on GuruFocus' analysis, Riken Vitamin Co (TSE:4526) is currently considered Fairly Valued. The stock's GF Value™ is 円2,913.14, compared to a current price of 円3,155.00 — trading 8.3% above its estimated fair value. The current Operating Income is 円6,901 Mil. Riken Vitamin Co's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Riken Vitamin Co (TSE:4526), the current Operating Income is 円6,901 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Riken Vitamin Co (TSE:4526) Overvalued in 2026?
Based on GuruFocus' analysis, Riken Vitamin Co stock appears to be overvalued.
The current stock price of 円3,155.00 is trading 8.3% above its estimated GF Value™ of 円2,913.14.
GuruFocus considers Riken Vitamin Co to be Fairly Valued.
Key valuation signals for TSE:4526:
Operating Income: 円6,901 Mil
GF Value™: 円2,913.14 vs. price of 円3,155.00 (8.3% above fair value)
No single metric tells the full story. See the TSE:4526 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Riken Vitamin Co Ltd is a Japan based animal food manufacturing company. It is a developer and producer of a wide variety of improvers that is broadly used to improve the texture and quality of processed food. It is engaged in consumer and commercial foods, processed food ingredients, food chemicals for industrial uses and Vitamin production and sales. The company's food emulsifiers are used in various applications such as cakes, bread, noodles, ice cream, as well as fat and oil food product. In addition to emulsifiers, Riken Vitamin also provides a range of other food improvers for various purposes according to relevant consumer needs.
76GF Score
Get the complete analysis for TSE:4526
Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4526 has been successfully added to your 
